You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 291 No. 24, June 23/30, 2004 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Medical News & Perspectives
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (2)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Oncology
 •Breast Cancer
 •Women's Health
 •Women's Health, Other
 •Prognosis/ Outcomes
 •Genetics
 •Genetic Counseling/ Testing/ Therapy
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Breast Cancer Gene Chip Study Under Way

Can New Technology Help Predict Treatment Success?

Tracy Hampton, PhD

JAMA. 2004;291:2927-2930.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

A crystal ball—now that is a tool oncologists would embrace. How many times have they advised patients to undergo chemotherapy, radiation, or both, knowing full well that at the end of treatment, these patients will likely have to wait years before knowing if they have truly beaten the disease?

The search for prognostic and predictive markers of treatment outcomes has been an ongoing effort for decades. "We all want to have a golden hit—the one and only factor that tells you whether the patient is likely to go on to die or likely to survive," said Emiel Rutgers, MD, a breast surgeon at the Netherlands Cancer Institute, in Amsterdam. "But it's never happened because cancer is a multifactorial thing," he added.

Now, though, scientists are finding ways to look at cancer in a multifactorial way—through analysis of tumor samples by DNA microarrays, or gene chips, which measure . . . [Full Text of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.